Singapore Health Sciences Authority - National regulatory authority for health products in Singapore
显示 2025 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| Lormalzi Concentrate for Solution for Infusion 350mg/20mL | DKSH SINGAPORE PTE. LTD. | Lormalzi Concentrate for Solution for Infusion 350mg/20mL | Mar 11, 2025 | SIN17201P |
| DUOCOXIB FILM COATED TABLET 90 MG | DUOPHARMA (SINGAPORE) PTE. LTD. | DUOCOXIB FILM COATED TABLET 90 MG | Mar 11, 2025 | SIN17202P |
| DUOCOXIB FILM COATED TABLET 120 MG | DUOPHARMA (SINGAPORE) PTE. LTD. | DUOCOXIB FILM COATED TABLET 120 MG | Mar 11, 2025 | SIN17203P |
| POSATIF POSACONAZOLE GASTRO-RESISTANT TABLETS 100MG | MEDICELL PHARMACEUTICAL (S) PTE. LTD. | POSATIF POSACONAZOLE GASTRO-RESISTANT TABLETS 100MG | Mar 10, 2025 | SIN17200P |
| ALPHAGAN P OPHTHALMIC SOLUTION 0.1% w/v | ABBVIE PTE. LTD. | ALPHAGAN P OPHTHALMIC SOLUTION 0.1% w/v | Mar 7, 2025 | SIN17198P |
| DAPAGLIFLOZIN SANDOZ FILM COATED TABLET 10MG | SANDOZ SINGAPORE PTE. LTD. | DAPAGLIFLOZIN SANDOZ FILM COATED TABLET 10MG | Mar 7, 2025 | SIN17199P |
| VYLOY™ POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL | ASTELLAS PHARMA SINGAPORE PTE. LTD. | VYLOY™ POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL | Mar 6, 2025 | SIN17197P |
| VEOZA™ FILM-COATED TABLETS 45 MG | ASTELLAS PHARMA SINGAPORE PTE. LTD. | VEOZA™ FILM-COATED TABLETS 45 MG | Mar 5, 2025 | SIN17196P |
| DEXTENZA Ophthalmic Insert 0.4 mg | LABCORP DEVELOPMENT (ASIA) PTE. LTD. | DEXTENZA Ophthalmic Insert 0.4 mg | Mar 5, 2025 | SIN17195P |
| PANSIPTIN FILM COATED TABLETS 100MG | GOLDPLUS UNIVERSAL PTE LTD | PANSIPTIN FILM COATED TABLETS 100MG | Mar 4, 2025 | SIN17192P |
| PANSIPTIN FILM COATED TABLETS 25MG | GOLDPLUS UNIVERSAL PTE LTD | PANSIPTIN FILM COATED TABLETS 25MG | Mar 4, 2025 | SIN17194P |
| PANSIPTIN FILM COATED TABLETS 50MG | GOLDPLUS UNIVERSAL PTE LTD | PANSIPTIN FILM COATED TABLETS 50MG | Mar 4, 2025 | SIN17193P |
| VESSOSMIN FILM COATED TABLET 500MG | GOLDPLUS UNIVERSAL PTE LTD | VESSOSMIN FILM COATED TABLET 500MG | Mar 4, 2025 | SIN17191P |
| TERLIPRESSIN-AFT SOLUTION FOR INJECTION 0.85MG/8.5ML | APEX PHARMA MARKETING PTE. LTD. | TERLIPRESSIN-AFT SOLUTION FOR INJECTION 0.85MG/8.5ML | Feb 28, 2025 | SIN17190P |
| HYMPAVZI SOLUTION FOR INJECTION IN SINGLE-DOSE PRE-FILLED PEN 150 MG/ML | PFIZER PRIVATE LIMITED | HYMPAVZI SOLUTION FOR INJECTION IN SINGLE-DOSE PRE-FILLED PEN 150 MG/ML | Feb 27, 2025 | SIN17187P |
| SUNLENCA SOLUTION FOR INJECTION 463.5MG/1.5ML | GILEAD SCIENCES SINGAPORE PTE. LTD. | SUNLENCA SOLUTION FOR INJECTION 463.5MG/1.5ML | Feb 27, 2025 | SIN17189P |
| SUNLENCA FILM-COATED TABLET 300MG | GILEAD SCIENCES SINGAPORE PTE. LTD. | SUNLENCA FILM-COATED TABLET 300MG | Feb 27, 2025 | SIN17188P |
| RYKINDO EXTENDED-RELEASE INJECTABLE SUSPENSION 50MG/VIAL | LUYE PHARMA (SINGAPORE) PTE. LTD. | RYKINDO EXTENDED-RELEASE INJECTABLE SUSPENSION 50MG/VIAL | Feb 20, 2025 | SIN17185P |
| RYKINDO EXTENDED-RELEASE INJECTABLE SUSPENSION 25MG/VIAL | LUYE PHARMA (SINGAPORE) PTE. LTD. | RYKINDO EXTENDED-RELEASE INJECTABLE SUSPENSION 25MG/VIAL | Feb 20, 2025 | SIN17183P |
| ELFABRIO CONCENTRATE FOR SOLUTION FOR INFUSION 2 MG/ML | ORIENT EUROPHARMA PTE LTD | ELFABRIO CONCENTRATE FOR SOLUTION FOR INFUSION 2 MG/ML | Feb 20, 2025 | SIN17186P |
